RF 1051: Will start this week a Phase I/II trial in severe chronic obesity in 8-16 patients whose levels of the undisclosed steroid are low. The dose-escalation

SuperGen Inc.
Product: RF 1051,

Read the full 51 word article

How to gain access

Continue reading with a
two-week free trial.